Is progesterone (progestin) required when a patient is receiving estrogen therapy?

Progesterone Requirement with Estrogen Therapy

Yes, you absolutely must take progesterone (or a progestin) if you are on estrogen therapy AND you still have your uterus. 11

The Critical Rule: Uterus Present = Progestogen Required

In women with a uterus, a progestogen must be added to prevent endometrial hyperplasia and cancer. 1 This is not optional—it is a mandatory requirement for endometrial protection. The evidence is unequivocal:

• Unopposed estrogen therapy increases endometrial cancer risk by 2 to 12 times compared to non-users 2
• The risk escalates dramatically with duration: 15- to 24-fold increase with 5-10 years of unopposed estrogen use 2
• This elevated risk persists for 8 to 15 years after stopping estrogen therapy 2

When You DON'T Need Progesterone

If you have had a hysterectomy (uterus removed), you do NOT need progesterone. 1 In this case, estrogen-only therapy is appropriate since there is no endometrium to protect.

How Progestogens Are Given

The progestogen can be administered through multiple routes 11:

Two main regimens exist:

1. Sequential (cyclical): Estrogen for 20-25 days + progestogen for 12-15 days each month

   • Preferred for recently menopausal women prone to breakthrough bleeding in the first 1-2 years

2. Continuous combined: Both estrogen and progestogen daily without interruption

   • Generally preferred for long-term use

Routes of administration include oral, transdermal patch, vaginal, or intrauterine device (levonorgestrel IUD) 11

Important Exception: Low-Dose Vaginal Estrogen

Low-dose vaginal estrogen preparations used specifically for genitourinary symptoms typically do NOT require concomitant progesterone. However, high-dose vaginal creams (1-2g of estradiol or conjugated estrogens) DO result in systemic estrogen levels and require progestogen protection 11

Alternative Option: CEE/Bazedoxifene

Where available, the combination of conjugated equine estrogens with bazedoxifene (a selective estrogen receptor modulator) provides an alternative that does not require separate progestogen therapy for women with a uterus 1. This combination provides endometrial protection through the SERM component rather than progesterone.

Critical Pitfalls to Avoid

• Never use unopposed estrogen in a woman with an intact uterus, regardless of dose or duration
• Custom-compounded progesterone lacks FDA oversight and has no clinical trial data documenting efficacy for endometrial protection 1
• The type of progestogen matters: recent evidence suggests different progestogens may have varying effects on breast cancer risk 34, though all provide endometrial protection when used appropriately

Monitoring Requirements

Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken for any undiagnosed persistent or recurring abnormal genital bleeding 2. This applies to all women on combined hormone therapy, as breakthrough bleeding may signal inadequate endometrial protection.